Zomedica CEO Issues Shareholder Letter as TRUFORMA™ Nears Commercialization

Rhea-AI Summary

Zomedica Corp. (NYSE American: ZOM) provided a shareholder update on key developments. CEO Robert Cohen expressed optimism for 2021, highlighting progress in product development and strategic initiatives. Zomedica focuses on innovative point-of-care diagnostic tools for veterinary use, aimed at enhancing pet healthcare. The company outlines its commitment to improving diagnostics for dogs and cats, creating potential for growth in the veterinary sector. Zomedica aims to bolster its market presence while addressing the challenges posed by the ongoing global pandemic.

Positive

• Zomedica is committed to innovative product development in veterinary diagnostics.
• The company aims to enhance pet healthcare through new diagnostic tools.
• Optimism expressed for growth potential in 2021.

Negative

• Ongoing global pandemic presents challenges to business operations.

ANN ARBOR, Mich., Jan. 18, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today issued the following letter from Robert Cohen, Chief Executive Officer, updating Zomedica’s shareholders regarding several key activities and events:

Dear Shareholders:

I am hopeful that you had a pleasant holiday season and wish you the best during the new year. We at Zomedica are excited as we enter

FAQ

What updates did Zomedica provide to shareholders on January 18, 2021?

Zomedica updated shareholders on key activities, emphasizing progress in product development and strategic initiatives.

What is Zomedica's focus in the veterinary health market?

Zomedica focuses on creating point-of-care diagnostic products for dogs and cats.

What are Zomedica's growth prospects for 2021?

Zomedica expressed optimism for growth potential in 2021, aiming to enhance its market presence.

How is Zomedica addressing challenges posed by the pandemic?

Zomedica acknowledged ongoing global pandemic challenges affecting business operations.

What is the stock symbol for Zomedica Corp.?

Zomedica Corp. trades under the stock symbol ZOM on the NYSE American.